These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25960051)

  • 41. Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells.
    Welter-Stahl L; da Silva CM; Schachter J; Persechini PM; Souza HS; Ojcius DM; Coutinho-Silva R
    Biochim Biophys Acta; 2009 May; 1788(5):1176-87. PubMed ID: 19306841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
    Dubyak GR; el-Moatassim C
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C577-606. PubMed ID: 8214015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autocrine and paracrine purinergic signaling in the most lethal types of cancer.
    Reyna-Jeldes M; Díaz-Muñoz M; Madariaga JA; Coddou C; Vázquez-Cuevas FG
    Purinergic Signal; 2021 Sep; 17(3):345-370. PubMed ID: 33982134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of purinergic receptors in retinal function and disease.
    Ward MM; Puthussery T; Vessey KA; Fletcher EL
    Adv Exp Med Biol; 2010; 664():385-91. PubMed ID: 20238039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
    Santini E; Cuccato S; Madec S; Chimenti D; Ferrannini E; Solini A
    Endocrinology; 2009 Jun; 150(6):2596-602. PubMed ID: 19196799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():41. PubMed ID: 17584495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purinergic receptors and pain.
    Burnstock G
    Curr Pharm Des; 2009; 15(15):1717-35. PubMed ID: 19442186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel aspects of glutamatergic signalling in the neuroendocrine system.
    Hrabovszky E; Liposits Z
    J Neuroendocrinol; 2008 Jun; 20(6):743-51. PubMed ID: 18601697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purinergic signalling: what is missing and needed next? The use of transgenic mice, crystallographic analysis and MicroRNA.
    Volonté C; Parisi C; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):751-67. PubMed ID: 22963439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular signalling by nucleotide receptors in PC12 pheochromocytoma cells.
    Raha S; de Souza LR; Reed JK
    J Cell Physiol; 1993 Mar; 154(3):623-30. PubMed ID: 8436608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dimerization of G protein-coupled purinergic receptors: increasing the diversity of purinergic receptor signal responses and receptor functions.
    Nakata H; Suzuki T; Namba K; Oyanagi K
    J Recept Signal Transduct Res; 2010 Oct; 30(5):337-46. PubMed ID: 20843271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective inhibition of beta(2)-adrenergic receptor-mediated cAMP generation by activation of the P2Y(2) receptor in mouse pineal gland tumor cells.
    Suh BC; Kim JS; Namgung U; Han S; Kim KT
    J Neurochem; 2001 Jun; 77(6):1475-85. PubMed ID: 11413231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of purinergic receptors in CNS function and neuroprotection.
    Tozaki-Saitoh H; Tsuda M; Inoue K
    Adv Pharmacol; 2011; 61():495-528. PubMed ID: 21586368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purinergic signaling in oligodendrocyte development and function.
    Welsh TG; Kucenas S
    J Neurochem; 2018 Apr; 145(1):6-18. PubMed ID: 29377124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
    Yoshioka K; Nakata H
    J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uridine-5'-triphosphate and adenosine triphosphate gammaS induce mucin secretion via Ca2+-dependent pathways in human nasal epithelial cells.
    Choi JY; Namkung W; Shin JH; Yoon JH
    Acta Otolaryngol; 2003 Dec; 123(9):1080-6. PubMed ID: 14710912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purinergic Signaling in Mast Cell Degranulation and Asthma.
    Gao ZG; Jacobson KA
    Front Pharmacol; 2017; 8():947. PubMed ID: 29311944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
    Reifel Saltzberg JM; Garvey KA; Keirstead SA
    Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular purines and their receptors in immunoregulation. Review of recent advances.
    Sitkovsky MV
    Nihon Ika Daigaku Zasshi; 1998 Oct; 65(5):351-7. PubMed ID: 9808987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.